U.S. flag

An official website of the United States government

NM_006295.3(VARS1):c.614_616del (p.Gly205del) AND Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Aug 14, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004720218.2

Allele description [Variation Report for NM_006295.3(VARS1):c.614_616del (p.Gly205del)]

NM_006295.3(VARS1):c.614_616del (p.Gly205del)

Genes:
LOC126859651:CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:31759783-31760982 [Gene]
VARS1:valyl-tRNA synthetase 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
6p21.33
Genomic location:
Preferred name:
NM_006295.3(VARS1):c.614_616del (p.Gly205del)
HGVS:
  • NC_000006.12:g.31792804_31792806del
  • NG_028229.1:g.8132_8134del
  • NG_084152.1:g.899_901del
  • NM_006295.3:c.614_616delMANE SELECT
  • NP_006286.1:p.Gly205del
  • NC_000006.11:g.31760581_31760583del
Protein change:
G205del
Molecular consequence:
  • NM_006295.3:c.614_616del - inframe deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy
Identifiers:
MONDO: MONDO:0060621; MedGen: C4540493; OMIM: 617802

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005200501Pediatrics, Sichuan Provincial Hospital For Women And Children
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Aug 14, 2024)
maternalreference population

PubMed (1)
[See all records that cite this PMID]

SCV005416758Juno Genomics, Hangzhou Juno Genomics, Inc
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedmaternalyesnot providednot providednot providednot providednot providedreference population

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Pediatrics, Sichuan Provincial Hospital For Women And Children, SCV005200501.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedreference population PubMed (1)

Description

The phenotype of this child is microcephaly and premature infantile epilepsy. ACGM: VARS1 variation c.614_616del was classified as likely pathogenic. PM2_Supporting+PM4+PM3+PP4. PM2_Supporting: This variant occurs very infrequently in the ExAC, gnomAD, Thousand-genome Asian population database. PM4: VARS1 gene variant c.614_616del is an inframe deletion mutation that results in a change in protein length. PM3: In this sample, another possible pathogenic variant, c.3203C>T, was detected at the trans position. PP4: The client's clinical symptoms were consistent with the dominant phenotype of NDMSCA.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providednot providednot providednot providednot providednot provided

From Juno Genomics, Hangzhou Juno Genomics, Inc, SCV005416758.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

PM2_Supporting+PM4+PM3+PP4

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024